Liver Transplant Guide

How do I find the right team for me?

mibaruch — Thu, 18 Dec 2025 19:34:14 +0000

Blog · Pre-Transplant Guide · Choosing Your Team

How Do I Find The Right Team For Me?

A practical, data-driven way to compare liver (and transplant) programs: outcomes, volume, waitlist size, staffing, and complications—plus the questions that reveal fit. [1] [2]

Date: December 17, 2025 | Author: Dr. Michael Baruch

Overview

“The best program” is rarely universal. The best program for you is the one that combines solid outcomes, appropriate experience with patients like you, a reasonable path to transplant (or the best non-transplant care if you’re not there yet), and a team you trust to manage complications quickly and transparently. [1]

The good news: in the U.S., there is publicly reported transplant-center data designed specifically to help patients compare programs—especially through SRTR and OPTN resources. [3] [4]

Key idea: Pick your shortlist using data, then pick your final program using fit—communication, coordination, access, and support.

Choosing a center is a family decision: SRTR patient resources emphasize comparing programs and finding the best fit. [1]

What “Right” Means (For Real Life)

The “right team” is typically the team that can do four things well:

Accurately stage your disease and explain the plan in plain language (even when it is complex).
Coordinate fast (testing, consults, insurance, listing steps) and respond when you worsen.
Manage complications early (ascites, varices, encephalopathy, infections, kidney strain) to reduce hospitalizations and setbacks.
Show you the numbers—their volume, waitlist experience, and outcomes—without defensiveness. [3] [5]

Practical framing: Data gets you to a shortlist. Communication and logistics determine whether the program can carry you through a rough week safely. [1]

Facility Statistics to Compare

Use SRTR’s center search and Program-Specific Reports (PSRs) to compare programs on standardized metrics. PSRs include information about candidates waiting, waitlist outcomes, transplant recipients, donors, and post-transplant outcomes. [2] [3]

What to compare	Where to find it	Why it matters	How to interpret it safely
Volume # of liver transplants performed	SRTR center search / “Full Report” and PSR tables [1] [2]	Experience with surgical complexity, ICU workflows, and complications.	Higher volume can help, but “fit” and patient mix matters; compare programs that treat patients like you. [1]
Active patients waitlist size (active candidates)	SRTR center “Full Report” / PSR waitlist tables [1] [2]	Signals program scale and throughput; helps you ask about access and staffing ratios.	A large list isn’t automatically good or bad—ask how coordinators manage communication and urgent changes. [1]
Getting a transplant faster (transplant rate)	SRTR 5-tier outcomes / PSR figures [6]	Programs differ in how quickly candidates get transplanted (case mix and acceptance practices matter).	Compare within your region when possible; ask what offers they accept and why. [6]
Waitlist survival (pre-transplant mortality)	SRTR 5-tier outcomes / PSR figures [6]	Reflects risk management while waiting—monitoring, escalation, and access.	Not purely “center quality”—severity of patients differs; still valuable as a safety signal. [6]
1-year graft survival	SRTR 5-tier outcomes / PSR post-transplant outcomes [6]	One-year outcomes capture surgical, inpatient, and early outpatient performance.	Look at trends across reports (not one snapshot). Ask what they do when outcomes dip. [2]
Center data (national context)	OPTN center data reports [4]	Provides broader context on activity and system-level data.	Use to understand trends; use SRTR PSRs for program-level comparisons. [4] [2]

One-minute shortcut: Use SRTR’s “Find a Transplant Center,” open each program’s “Full Report,” then capture four numbers: volume, active waitlist size, transplant rate tier, and 1-year graft survival tier. [1] [6]

Board-Certified Team and Services to Confirm

Outcomes do not come from surgeons alone. A transplant program is a system: hepatology, surgery, anesthesia/ICU, infectious disease, pharmacy, radiology/interventional radiology, social work, nutrition, and a coordinator infrastructure that can move fast. [5]

Minimum “must-have” questions (and why they matter):

Are your transplant hepatologists board-certified? (Ask who manages cirrhosis complications day-to-day.)
How many surgeons do liver transplants here? (Ask about coverage nights/weekends.)
Coordinator ratio: How many active waitlist patients per coordinator?
24/7 escalation: Who answers when you have fever, confusion, GI bleeding, or sudden swelling?
Access: Typical time to return calls/portal messages; urgent labs; same-week clinic availability.

Regulatory baseline: U.S. transplant programs must meet Medicare requirements tied to data submission, experience, and outcomes—this supports minimum quality expectations. [5]

Why the team matters: the liver drives metabolism, clotting factors, and fluid balance—complications can evolve fast, so coordination matters. [7]

Complications and Safety Signals

No program can promise “no complications.” What you can assess is whether the program recognizes complications early and manages them reliably. The SRTR outcome framework explicitly helps the public compare outcomes including pre-transplant mortality, transplant rate, and early post-transplant graft survival. [6]

Ask specifically about the complications that change lives:

While waiting: variceal bleeding, infections, worsening ascites, encephalopathy episodes, and kidney injury—how are these handled? [1]
Immediately after transplant: early graft dysfunction, bleeding, biliary complications, vascular complications, infections, and rejection—what is their typical pathway and follow-up cadence?
Readmissions: How often do patients return to the hospital within 30–90 days, and what are the top causes at your center?
Patient support and adherence: social work, medication education, pharmacy access, and infection prevention coaching—how is this delivered?

How to interpret “statistics” wisely: When you compare centers, use the SRTR “full report” metrics to start the conversation, then ask how the program’s patient mix and acceptance practices influence those outcomes. [1] [2]

What to Do Now (Checklist)

Make a shortlist of 2–4 programs using SRTR search (distance + data). [1]
Pull each program’s “Full Report” / PSR highlights: volume, active waitlist size, transplant rate tier, waitlist survival tier, 1-year graft survival tier. [2] [6]
Call the program and ask three logistics questions: coordinator response time, after-hours escalation, and typical evaluation timeline.
Confirm insurance pathway (in-network, travel requirements, transplant pharmacy coverage).
Bring one page to your visit: your history, meds, recent labs/imaging, and your “questions to ask” list.

If you can only do one thing today: open SRTR, find the liver programs you’re considering, and screenshot the “Full Report” summary icons so you can compare side-by-side. [1] [6]

Questions to Ask Your Liver or Transplant Team

Statistics / facility: “How many liver transplants did you do last year, and how many active liver candidates are on your waitlist right now?” [2]
Outcomes: “Where do your current SRTR tiers fall for transplant rate, waitlist survival, and 1-year graft survival—and what are you doing to improve any area that is not strong?” [6]
Team credentials: “Who will manage my cirrhosis complications—your transplant hepatology group—and how do I reach them urgently?” [5]
Complications: “What are your most common early complications after liver transplant here, and what is your standard pathway to detect them early?”
Coordinator capacity: “How many patients does a coordinator typically manage, and what is your response-time expectation?”
Fit: “If I worsen suddenly (confusion, fever, GI bleeding, rapid swelling), what is the exact plan—who do I call, and where do I go?”

References

SRTR (Patient & Families). Find a Transplant Center (how to compare and what to expect).
SRTR. Program-Specific Reports (PSRs): candidates waiting, waitlist outcomes, recipients, donors, and outcomes after transplant.
SRTR. Find and Compare Transplant Programs (public reporting platform).
OPTN/HRSA. Center data reports (national transplant activity and center-level data).
CMS. Organ Transplant Program requirements (Medicare approval, data submission, experience, outcomes).
SRTR. 5-Tier Outcome Assessment (waitlist survival, transplant rate, 1-year organ survival).
NIDDK/NIH. Media Library Asset: Location of the liver within the human body (educational image).

Medical Disclaimer: This page is for educational purposes only. It does not provide medical advice, diagnosis, or treatment and does not create a doctor–patient relationship. Decisions must be made with a licensed clinician and (when relevant) a transplant team. Seek urgent or emergency care for vomiting blood, black or bloody stools, fainting, severe confusion, fever, severe abdominal pain, shortness of breath, or any sudden concerning symptoms—especially if new, severe, or worsening.

← Return to Pre-Transplant Guide

What do I do if I have liver disease?

mibaruch — Thu, 18 Dec 2025 19:15:45 +0000

← Return to Pre-Transplant Guide

Blog · Next Steps · Liver Health

What Do I Do If I Have Liver Disease?

A practical, step-by-step plan: confirm what you have, reduce the driver, monitor what matters, and know when care is urgent. [1] [2]

Overview

“Liver disease” is an umbrella term—it can mean mild inflammation, fatty liver, significant fibrosis, or cirrhosis. The right next step depends on cause (alcohol, metabolic/MASLD, viral hepatitis, autoimmune, medication-related, etc.) and stage (no scarring vs advanced scarring). [1] [3]

The goal is not to “Google your way to certainty.” The goal is to take organized action: confirm the diagnosis, stop the driver, prevent complications, and make sure you know what symptoms are emergencies. [2]

Quick take: If you do only two things this week: (1) clarify the cause and stage, and (2) ask what would trigger urgent care. [2] [6]

Educational image: normal → fatty → fibrosis → cirrhosis (NIDDK/NIH). [4]

First 48 Hours: Get Oriented

Confirm what “liver disease” means in your case. Ask: “Do I have fatty liver, fibrosis, cirrhosis, hepatitis, or something else?” [1]
Clarify cause (etiology). The cause drives treatment: alcohol-associated liver disease, MASLD/MASH, hepatitis B/C, autoimmune hepatitis, medication/toxin, hereditary conditions, and more. [3] [7]
Clarify stage (especially whether cirrhosis is present). Cirrhosis means permanent scarring and higher risk of complications; many people don’t feel symptoms until late. [2]
Ask whether a hepatology referral is appropriate. Referral is especially important if there are complications, suspected decompensation, or need for endoscopy/HCC surveillance. [5]

Stabilize the Basics (What You Can Control)

Most liver diseases improve when the driver is removed or controlled—sometimes dramatically. Your clinician should guide the plan, but these are common pillars: [1]

If alcohol is the driver: stopping alcohol is foundational (and often urgent). Ask about safe withdrawal planning if you drink heavily. [7]
If MASLD/MASH is the driver: metabolic management (weight, diabetes, lipids, BP) matters because it changes progression risk. [8]
If viral hepatitis is the driver: treatment and monitoring can change long-term outcomes and reduce complications. [9] [10]
If autoimmune hepatitis is the driver: controlling immune-mediated inflammation reduces progression risk (requires specialist oversight). [11]
Medication safety: do not start supplements or “liver cleanses” without your team; review all meds (including OTC and herbals). [1]

Practical tip: Bring a one-page list to appointments: medications, alcohol history (if any), metabolic conditions, family history, and your last labs/imaging dates. [1]

Educational image: normal tissue vs cirrhotic tissue (NIDDK/NIH). [12]

Monitoring and Follow-Up (What Teams Track)

Monitoring depends on stage. In earlier disease, the focus is on cause control and fibrosis risk. In cirrhosis, the focus expands to complications, surveillance, and transplant planning when appropriate. [2] [5]

Labs and trends: liver enzymes (AST/ALT), bilirubin, INR, albumin, platelets, and kidney function are commonly used to assess severity and trajectory. [2]
Fibrosis assessment: elastography and/or other noninvasive tests may be used to estimate scarring and monitor change over time. [1]
If cirrhosis: outpatient management includes preventing/monitoring complications (ascites, encephalopathy, variceal bleeding) and ensuring appropriate surveillance/referral. [5]
Ascites is a major inflection point: clinically significant ascites and related complications should prompt consideration of transplant evaluation (when appropriate). [13]

Transplant reality (non-alarmist): The best time to learn about transplant evaluation is often before a crisis forces it. [5] [13]

When It’s Urgent (Do Not Wait)

Liver disease can worsen quickly, especially when bleeding, infection, dehydration, kidney injury, or encephalopathy enter the picture. If any of the following occur, seek urgent/emergency care based on your team’s instructions and local emergency services. [6]

Vomiting blood or black/tarry stools (possible GI bleeding). [6]
Severe confusion, extreme sleepiness, or inability to stay awake/answer normally (possible encephalopathy). [6]
Fever with abdominal pain/tenderness or rapidly worsening swelling (possible infection such as SBP—especially in cirrhosis). [13]
New or rapidly worsening jaundice, severe abdominal pain, fainting, or shortness of breath. [14] [15]

Safety note: If you are ever unsure whether symptoms are urgent, it is reasonable to err on the side of seeking immediate medical evaluation. [6]

Questions to Ask Your Clinician or Transplant Team

What is the most likely cause of my liver disease, and what is the plan to treat that cause? [3]
What is my current stage (fatty liver, fibrosis, cirrhosis), and what test supports that conclusion? [2]
Do I have any signs of decompensation (ascites, bleeding risk, encephalopathy), and what should I do if symptoms appear? [5] [6]
How often should I have labs/imaging, and which results matter most to you (trend vs single value)? [1]
Should I be referred to hepatology—and if cirrhosis or significant ascites is present, is transplant evaluation appropriate to discuss now? [5] [13]

References

AASLD. Practice Guidelines (evidence-based guidance for clinicians; useful starting point for what “standard evaluation/management” means).
NIDDK/NIH. Cirrhosis: Definition & Facts (overview; notes many people have no symptoms until late).
NCBI Bookshelf (NIH) — StatPearls. Hepatic Cirrhosis (overview of causes and progression framework).
NIDDK/NIH Media Asset. Normal Liver, Fatty Liver, Liver Fibrosis, and Cirrhosis (image; please credit NIDDK/NIH).
AASLD Liver Fellow Network. Back to Basics: Outpatient Management of Cirrhosis (referral considerations; ambulatory management framework).
U.S. Department of Veterans Affairs (VA). Cirrhosis: When to go to the emergency room (patient guidance on bleeding/confusion red flags).
Crabb DW, Im GY, Szabo G, et al. (PubMed). Diagnosis and treatment of alcohol-associated liver diseases (AASLD guidance framework).
Rinella ME, Lazarus JV, Ratziu V, et al. (PubMed). Consensus/guidance on NAFLD/MASLD (metabolic drivers and management direction).
CDC. Hepatitis C: Signs and symptoms (patient-facing symptom guidance).
CDC. Hepatitis B: Symptoms (patient-facing symptom guidance).
Manns MP, Lohse AW, Vergani D. (PubMed). Autoimmune hepatitis (diagnosis/management principles and outcomes overview).
NIDDK/NIH Media Asset. Portions of normal and cirrhotic liver tissues (image; please credit NIDDK/NIH).
AASLD. Diagnosis, Evaluation and Management of Ascites, SBP, and HRS (notes transplant evaluation considerations in clinically significant ascites).
NIDDK/NIH. Cirrhosis (patient overview and complications context).
CDC. Clinical Signs and Symptoms of Hepatitis B (clinical-oriented list including jaundice/dark urine/clay stools).

Medical Disclaimer: This page is for educational purposes only. It does not provide medical advice, diagnosis, or treatment and does not create a doctor–patient relationship. Decisions must be made with your licensed clinician and transplant team. Seek urgent or emergency care for vomiting blood, black or bloody stools, fainting, severe confusion, fever, severe abdominal pain, shortness of breath, or any sudden concerning symptoms—especially if symptoms are new, severe, or worsening.

← Return to Pre-Transplant Guide

Do I have liver disease?

mibaruch — Thu, 18 Dec 2025 19:07:13 +0000

← Return to Blog Archive

Hepatic Haven · Blog · Early Detection

Do I Have Liver Disease?

A calm, practical way to think through symptoms, labs, and risk factors—before panic or denial takes over. [2]

Published: December 18, 2025 · Author: Dr. Michael Baruch

DO I HAVE LIVER DISEASE — OVERVIEW Common signs Labs & patterns Risk factors What to do next Questions to ask References

Overview

This is usually how it starts: a “mildly elevated liver test,” a strange fatigue you can’t explain, a comment on an ultrasound, or a family member who looks at you and says, “Maybe you should get checked.” The problem is that liver disease rarely announces itself cleanly. Many people feel normal for years because the liver has significant physiologic reserve. That resilience is helpful—until it isn’t. The practical way forward is a structured approach: confirm abnormalities, classify the lab pattern, and then evaluate likely causes based on risk. [2]

The goal of this post is not to diagnose you. It is to help you think clearly and talk effectively with your clinician. If you’re early in the process, you need a plan that prevents two extremes: panic (“This must be cirrhosis”) and dismissal (“It’s probably nothing”). Many causes of liver injury are treatable—especially when identified early—and a stepwise evaluation is designed to find what matters without wasted testing. [3]

Quick take: Your best first question is not “How bad is it?” It’s “What pattern is this, is it persistent, and what is the most likely driver?” [1]

Educational image: progression from normal liver to cirrhosis (NIDDK/NIH). [4]

Common Signs (and Why They Can Mislead)

Educational image: where the liver sits in the body (NIDDK/NIH). [5]

Symptoms are a noisy signal. Fatigue, low appetite, mild nausea, or “brain fog” can occur in liver disease, but they also occur with sleep disruption, medication effects, thyroid disease, anemia, depression, and many other conditions. This is why clinicians rely heavily on objective patterns—labs, trends, imaging, and risk profile—rather than symptoms alone. A structured approach is specifically recommended for abnormal liver chemistries because it improves diagnostic accuracy and reduces unnecessary testing. [2]

Fatigue or low energy — common and nonspecific; important mainly when paired with abnormal labs or clear risk factors. [3]
Abnormal AST/ALT — the degree of elevation does not reliably reflect fibrosis stage; persistence and pattern are more informative. [1] [2]
Red flags (jaundice, confusion, vomiting blood, black stools, significant abdominal swelling) — can signal decompensation and require urgent evaluation. [6]

Practical rule: Vague symptoms → confirm trends and risks. Red flags → urgent evaluation. [6]

Labs & Patterns: “Enzymes” vs “Function”

A common misunderstanding is that “liver tests” always measure how well the liver works. Many common labs are markers of injury or bile flow. AST and ALT typically rise with hepatocellular injury; alkaline phosphatase is often higher with cholestatic/bile-duct patterns; bilirubin reflects processing and excretion. “Function” is more directly reflected by labs such as INR and albumin (and, clinically, platelet trends can suggest evolving portal hypertension over time). The recommended first step is to define the pattern (hepatocellular vs cholestatic vs mixed), confirm persistence, and then test likely causes based on history. [2]

This distinction matters because mild AST/ALT elevations can be transient (intercurrent illness, exercise, medications), while rising bilirubin/INR—especially with symptoms—can reflect limited reserve. A stepwise, pattern-based evaluation helps avoid both undertreatment and overtesting. [1] [2]

Ask this directly: “Is my pattern hepatocellular, cholestatic, or mixed—and what are the top causes for me?” [2]

Risk Factors That Warrant Evaluation

Liver disease usually has a driver. The most common drivers include metabolic liver disease (MASLD/MASH), alcohol-associated liver disease, chronic viral hepatitis, medication/supplement injury, autoimmune disease, and hereditary disorders. Guidance recommends risk-factor review early because it meaningfully improves diagnostic yield and helps clinicians choose targeted testing rather than broad panels without a plan. [2]

Metabolic risk (diabetes, obesity, metabolic syndrome) — associated with MASLD/MASH and fibrosis risk. [7]
Alcohol exposure (heavy/prolonged use) — abstinence can materially change trajectory; ongoing intake increases risk. [8]
Viral hepatitis exposure (HBV/HCV risk) — screening and treatment reduce progression. [9]
Persistent abnormalities, autoimmune history, or family history — warrants a deliberate workup. [1]

What to Do Next

The most effective next step is usually a structured visit with your clinician (primary care, gastroenterology, or hepatology). In general: confirm abnormal tests, define the pattern, and then test the most likely causes based on your risks and history. If abnormalities persist or risks are meaningful, ask whether fibrosis assessment is appropriate; modern noninvasive tests can help clarify risk and guide surveillance. [2] [10]

Today: gather your last 6–12 months of labs and imaging; list medications and supplements. [2]
This month: confirm persistence; ask for a stepwise plan; consider fibrosis assessment when appropriate. [10]
Emergency: go now for vomiting blood, black stools, severe confusion, fainting, severe shortness of breath, fever with worsening abdominal pain, or rapidly worsening jaundice. [6]

Clinic-ready wording: “I’d like to confirm transient vs persistent abnormalities, define the pattern, and evaluate the most likely causes based on my risk factors.” [1]

Questions to Ask Your Clinician

Which pattern do my labs fit (hepatocellular, cholestatic, mixed), and what are the top causes in my case? [2]
Should we repeat the panel, and if it stays abnormal, what is the stepwise plan? [2]
Do I need fibrosis assessment now, and how will it change surveillance or management? [10]
What red flags should trigger urgent care in my situation? [6]

References

AASLD Liver Fellow Network. How to approach elevated liver enzymes? (Back to Basics).
Kwo PY, Cohen SM, Lim JK. (American Journal of Gastroenterology, 2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
NIDDK/NIH. Liver disease overview (patient education).
NIDDK/NIH Media Asset. Normal liver, fatty liver, liver fibrosis, and cirrhosis (image).
NIDDK/NIH Media Asset. The location of the liver within the human body (image).
D’Amico G, Garcia-Tsao G, Pagliaro L. (PubMed). Natural history and prognostic indicators of survival in cirrhosis: systematic review.
NIDDK/NIH. NAFLD/MASLD overview (patient education).
Crabb DW, Im GY, Szabo G, et al. (PubMed). Diagnosis and treatment of alcohol-associated liver diseases.
Terrault NA, Lok ASF, McMahon BJ, et al. (PubMed). Update on prevention, diagnosis, and treatment of chronic hepatitis B.
AASLD Liver Fellow Network. Back to Basics: Non-invasive Testing for Liver Fibrosis.

Medical Disclaimer: This content is for educational purposes only and does not provide medical advice, diagnosis, or treatment, and it does not create a doctor–patient relationship. Seek urgent or emergency care for vomiting blood, black or bloody stools, fainting, severe confusion, fever with worsening abdominal pain, shortness of breath, rapidly worsening jaundice, or any sudden concerning symptoms. Always follow the guidance of your own licensed clinicians and transplant/hepatology team.

← Return to Blog Archive